Convergence of Genetic, Nutritional and Inflammatory Factors in Gastrointestinal Cancers
- 28 June 2008
- journal article
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 65 (suppl 3) , S157-S166
Abstract
Gastrointestinal cancers account for 20% of all cancer incidences worldwide. Colorectal cancer is the second most common cause of all cancer-related mortality and is increasing in Western societies. Infection and inflammation contribute to 15–20% of all malignancies, and are predisposing risk factors for gastrointestinal cancers. Helicobacter pylori infection is commonly associated with gastric cancers, and chronic inflammation increases the risk of colorectal cancer by 1% per year. Micronutrient status and common genetic variations in human populations modify risk for gastrointestinal cancer. Chronic inflammation promotes carcinogenesis by inducing gene mutations, inhibiting apoptosis, and stimulating an-giogenesis and cell proliferation. Inflammation also induces epigenetic alterations that are associated with cancer development. Two key genes in the inflammatory process, cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-kB), provide a mechanistic link between inflammation and cancer and are targets for chemoprevention. Dietary components, and human genetic variation that affects nutrient utilization, can directly modify inflammatory processes and/or suppress genomic alterations that are the molecular antecedents of cancers. The present report focuses on the convergence of genetic, nutritional, and inflammatory factors in the initiation and progression of gastrointestinal cancers, and the emerging dietary strategies for cancer prevention.Keywords
This publication has 71 references indexed in Scilit:
- In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-Like Receptor 4 and Induces Activation of MonocytesPLOS Medicine, 2006
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006
- NF‐κB and cancer: Mechanisms and targetsMolecular Carcinogenesis, 2006
- Tumour necrosis factor-α as a tumour promoterEuropean Journal of Cancer, 2006
- The Translation of Helicobacter pylori Basic Research to Patient CareGastroenterology, 2006
- COX-2: A Molecular Target for Colorectal Cancer PreventionJournal of Clinical Oncology, 2005
- Anatomical basis of tolerance and immunity to intestinal antigensNature Reviews Immunology, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000